OCT analysis of cystoid macular edema in uveitis patients undergoing anti-inflammatory treatment - ND

• Conditions: Cystoid macular edema in uveitis; MedDRA version: 9.1Level: LLTClassification code 10051240Term: Cystoid macular edema; MedDRA version: 9.1Level: LLTClassification code 10046851Term: Uveitis

• Registration Number: EUCTR2008-004899-50-IT
• Lead Sponsor: POLICLINICO UNIVERSITARIO AGOSTINO GEMELLI

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Study Start: 2008-07-23
• Last Update Posted: 10 February 2014

Recruitment & Eligibility

• Status: ot Recruiting
• Sex: All
• Target Recruitment: Not specified

Inclusion Criteria

Patients with a history of chronic anterior uveitis, intermediate uveitis or panuveitis with CME and without signs of acute ocular inflammation will be included
Are the trial subjects under 18? no
Number of subjects for this age range:
F.1.2 Adults (18-64 years) yes
F.1.2.1 Number of subjects for this age range
F.1.3 Elderly (>=65 years) yes
F.1.3.1 Number of subjects for this age range

Exclusion Criteria

Patients showing infectious uveitis, severe media opacities, diabetes, other maculopathies, steroid responders or patients with IOP equal or superior to 21 mmHg and pregnant women will be excluded from the study.

Study & Design

• Study Type: Interventional clinical trial of medicinal product
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Main Objective: Primary objective of the study is to assess the efficacy of sub-Tenon anti-inflammatory therapy (triamcinolone acetonide 40 mg) in patients affected by CME secondary to uveitis.;Secondary Objective: Secondary objective is to establish the relationship between OCT morphologic data and perimetric functional parameters.;Primary end point(s): n.d.